NCT04617535No Longer Available不适用
Compassionate Use of REGN-COV2 for the Treatment of COVID-19
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
Compassionate Use requests will be considered for individuals who test positive for SARS-CoV-2 and where there is reasonable basis to believe that the patient is infected with a susceptible variant.
详细描述
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
研究设计
- 研究类型
- Expanded Access
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in CommunityTreatment EfficacyNCT05087381Chulalongkorn University1,200
已完成
1 期
SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 PatientsCOVID-19NCT04521309Dow University of Health Sciences50
终止
2 期
Use of Convalescent Plasma for COVID-19COVIDNCT04408040Northside Hospital, Inc.8
已完成
不适用
COVID-19 Search in Conjunctival CellsCOVID 19Pulmonary DiseaseNCT04364594Fondazione Policlinico Universitario Agostino Gemelli IRCCS50
已完成
不适用
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)Covid19Neurologic ManifestationsPsychiatric ManifestationsNCT04568707Assistance Publique - Hôpitaux de Paris238